Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ZIP-1642
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
Details : Ziphius Vaccines is developing a proprietary self-amplifying mRNA technology platform combined with innovative lipid formulations for delivery. saRNA or replicon RNA has the advantage of having self-replicating features.
Product Name : ZIP-1642
Product Type : Vaccine
Upfront Cash : Undisclosed
June 23, 2022
Lead Product(s) : ZIP-1642
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Collaboration